NCT01806818

Comparing Efficacy and Safety Between Eperisone a BID and a TID Regimen in Acute Low Back Pain Patients

A Phase 2, Randomized, Double-blind, Parallel, Placebo-controlled, Multi-center Study to Compare Efficacy and Safety Between Eperisone a BID and a TID Regimen in Acute Low Back Pain Patients

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 98 (actual)
• Sponsor: Hanmi Pharmaceutical Company Limited · Industry
• Sex: All
• Age: 20 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

Multi-center Study to Compare Efficacy and Safety between Eperisone a BID and a TID Regimen in Acute Low Back Pain Patients during 7 days.

Conditions

• Low Back Pain

Interventions

Type	Name	Description
DRUG	Epirisone 50mg or placebo TID	3 times a day after meals for 1 week

Timeline

• Start date: 2013-02-01
• Primary completion: 2013-07-01
• Completion: 2013-07-01
• First posted: 2013-03-07
• Last updated: 2013-08-23

Locations

5 sites across 1 country: South Korea